Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
Giorgia Lodetti; Stefano Tambuzzi; Salvatore Andreola; Guendalina Gentile; Riccardo Zoja
Abstract
Uterine carcinosarcoma (USC), also known as malignant mixed Müllerian tumor, is a rare and high-grade endometrial cancer composed of epithelial and mesenchymal elements.
Typical UCS-related symptoms, unfortunately, associated with an already advanced stage of the disease, are large masses occupying the abdominal cavity, postmenopausal metrorrhagia, and abdominal pain. One of the most important complications of endometrial tumors, especially in UCS, is venous thromboembolism (VTE), with an incidence of 8.1%.
While Trans-Vaginal Sonography (TVS) is the first-line method for the assessment of UCS, as it can detect neoformations of the myometrium, diagnosis can usually be made by the histopathological examination of targeted endometrial biopsies, possibly associated with hysteroscopy.
Depending on the histopathologic assessment of the tumor (depth of invasion and presence or absence of metastases) and clinical presentation,
At the end of all investigations, the cause of death was identified as massive pulmonary arterial thrombosis in a subject with uterine carcinosarcoma.
For completeness, we also considered peritonitis and sepsis as possible co-participation in the cause of death. However, we considered this hypothesis unlikely based on the macroscopic and microscopic findings. Specifically, the peritoneum, abdominal viscera, and serosa were shiny, without fibrinous deposits, and of normal consistency. The purulent-looking material appeared free and not adherent to the abdominal wall and intestinal loops, as would be the case with recent extravasation, and was not organized. The histologic findings confirmed these considerations, which revealed no evidence of septic embolism. Overall, there were no postmortem findings suggestive of peritonitis and sepsis. Had the massive and acutely fatal pulmonary arterial thrombosis not occurred, local or systemic septic complications most likely could have developed.
The case was considered of interest because of the rare neoplasm, its size, and the very advanced stage of the disease. Another peculiarity was that one of the most lethal direct complications of this neoplasm, pulmonary arterial thrombosis, was observed. Unfortunately, the absence of family members and health information does not allow further clinical considerations, but the severity of the disease found is glaringly the result of neglected and untreated disease. This case demonstrates that such scenarios are still possible today, despite the increased importance of prevention campaigns. In this context, the observed anatomopathological findings are crucial as they enrich the knowledge of uterine carcinosarcoma, and their images may help forensic pathologists who have not previously encountered this rare disease.
References
1 Cantrell LA, Blank SV, Duska LR. Uterine carcinosarcoma: a review of the literature. Gynecol Oncol. 2015;137(3):581-8.
2 Kim SI, Kim JH, Lee C, Ha J, Jung KW, Lim MC. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study. J Gynecol Oncol. 2023;34(1):e9.
3 Matsuo K, Ross MS, Im DD, et al. Significance of venous thromboembolism in women with uterine carcinosarcoma. Gynecol Oncol. 2018;148(2):267-74.
4 Rauh-Hain JA, Hariton E, Clemmer J, et al. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol. 2015;125(6):1362-70.
5 Savelli L, Ceccarini M, Ludovisi E, et al. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008;31(5):560-6.
6 Epstein E, Van Holsbeke C, Mascilini F, et al. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size. Ultrasound Obstet Gynecol. 2011;38(5):586-93.
7 Tuan HX, Duc NM, Tri CM, Quyen HD, Dung PX. Carcinosarcoma of uterus. Radiol Case Rep. 2023;18(3):1297-301.
8 Abu-Rustum N, Yashar C, Arend R, et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(2):181-209.
Submitted date:
05/30/2023
Accepted date:
06/09/2023
Publication date:
07/13/2023